Bluebird Bio sees Europe as first market for its gene therapies – FierceBiotech
FierceBiotech |
Bluebird Bio sees Europe as first market for its gene therapies
FierceBiotech Bluebird Bio plans to bring its gene therapies to market in Europe before the U.S., thanks to a favorable regulatory pathway. Bluebird's vice president for immunotherapy, Richard Morgan, told the Daily Telegraph that the company is already in … |
